190 related articles for article (PubMed ID: 29031586)
1. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
Chen J; Li GQ; Zhang L; Tang M; Cao X; Xu GL; Wu YZ
Cancer Lett; 2018 Jan; 412():30-36. PubMed ID: 29031586
[TBL] [Abstract][Full Text] [Related]
2. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
Chen J; Sun ZH; Chen LY; Xu F; Zhao YP; Li GQ; Tang M; Li Y; Zheng QY; Wang SF; Yang XH; Wu YZ; Xu GL
Aging (Albany NY); 2020 Jul; 12(14):14285-14299. PubMed ID: 32669478
[TBL] [Abstract][Full Text] [Related]
3. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.
Maeda Y; Kawano Y; Wada Y; Yatsuda J; Motoshima T; Murakami Y; Kikuchi K; Imamura T; Eto M
Oncol Rep; 2015 Apr; 33(4):1844-50. PubMed ID: 25682807
[TBL] [Abstract][Full Text] [Related]
4. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
5. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.
Bosmann M; Haggadone MD; Hemmila MR; Zetoune FS; Sarma JV; Ward PA
J Immunol; 2012 May; 188(10):5086-93. PubMed ID: 22491257
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell function in allostimulation is modulated by C5aR signaling.
Peng Q; Li K; Wang N; Li Q; Asgari E; Lu B; Woodruff TM; Sacks SH; Zhou W
J Immunol; 2009 Nov; 183(10):6058-68. PubMed ID: 19864610
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
[TBL] [Abstract][Full Text] [Related]
8. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
9. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
Liu Y; Xu SQ; Long WJ; Zhang XY; Lu HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
[TBL] [Abstract][Full Text] [Related]
10. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
Kaida T; Nitta H; Kitano Y; Yamamura K; Arima K; Izumi D; Higashi T; Kurashige J; Imai K; Hayashi H; Iwatsuki M; Ishimoto T; Hashimoto D; Yamashita Y; Chikamoto A; Imanura T; Ishiko T; Beppu T; Baba H
Oncotarget; 2016 Dec; 7(51):84798-84809. PubMed ID: 27756879
[TBL] [Abstract][Full Text] [Related]
11. Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes.
Nitta H; Shimose T; Emi Y; Imamura T; Ohnishi K; Kusumoto T; Yamamoto M; Fukuzawa K; Takahashi I; Higashi H; Tsuji A; Akagi Y; Oki E; Maehara Y; Baba H;
Med Oncol; 2016 Nov; 33(11):118. PubMed ID: 27688239
[TBL] [Abstract][Full Text] [Related]
12. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
13. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions.
Wrann CD; Tabriz NA; Barkhausen T; Klos A; van Griensven M; Pape HC; Kendoff DO; Guo R; Ward PA; Krettek C; Riedemann NC
J Immunol; 2007 May; 178(9):5940-8. PubMed ID: 17442978
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes.
Zhang XY; Liu Y; He T; Yang TT; Wu J; Cianflone K; Lu HL
Biomed Pharmacother; 2018 Jul; 103():955-964. PubMed ID: 29710512
[TBL] [Abstract][Full Text] [Related]
15. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
17. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
19. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
[TBL] [Abstract][Full Text] [Related]
20. γδT-cell function in sepsis is modulated by C5a receptor signalling.
Han G; Geng S; Li Y; Chen G; Wang R; Li X; Ma Y; Shen B; Li Y
Immunology; 2011 Jul; 133(3):340-9. PubMed ID: 21501163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
